Browsing: biotech investing
Amgen announced today the positive top-line results from the Phase 3 MINT trial, evaluating the efficacy and safety of UPLIZNA…
Amgen (NASDAQ: AMGN) has released positive top-line results from the Phase 3 MINT trial, which evaluated the efficacy and safety…
Quantum BioPharma Ltd., a biopharmaceutical company focused on developing innovative assets and biotech solutions, has initiated legal action by filing…
Explore the fully interactive Multichannel News Release by clicking here: https://www2.multivu.com/amgen/9292951-en-la-la-anthony-amgen-partner-to-encourage-open-dialogue-about-plaque-psoriasis In a recent interactive video, La La provides a…
For a comprehensive and interactive experience, please explore the full Multichannel News Release by clicking on this link: [link to…
Experience the interactive Multichannel News Release in the provided link. The interactive video showcases La La offering a personal and…
Experience the full interactive Multichannel News Release by accessing the following link: https://www2.multivu.com/amgen/9292951-en-la-la-anthony-amgen-partner-to-encourage-open-dialogue-about-plaque-psoriasis. In a newly released interactive video, La…
Amgen’s Executive Vice President of Research and Development, Dr. Jay Bradner, emphasized the significance of TEPEZZA’s approval in Asia as…
The recent approval of TEPEZZA in Asia signifies a major step forward in the global treatment of Thyroid Eye Disease…
“The breadth of these data showcases our strategy to advance diverse modalities for difficult-to-treat cancers,” stated Jay Bradner, M.D., executive…